185 related articles for article (PubMed ID: 23143001)
21. Knockdown of Cathepsin L promotes radiosensitivity of glioma stem cells both in vivo and in vitro.
Wang W; Long L; Wang L; Tan C; Fei X; Chen L; Huang Q; Liang Z
Cancer Lett; 2016 Feb; 371(2):274-84. PubMed ID: 26706414
[TBL] [Abstract][Full Text] [Related]
22. Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling.
Annabi B; Lachambre MP; Plouffe K; Sartelet H; Béliveau R
Mol Carcinog; 2009 Oct; 48(10):910-9. PubMed ID: 19326372
[TBL] [Abstract][Full Text] [Related]
23. [Studies on the target cells and molecules with sodium valproate induced differential of human glioma cells].
Wang AD; Ji XY; Huang Q; Wang CR; Dong J; Lan Q
Zhonghua Wai Ke Za Zhi; 2007 Aug; 45(16):1121-4. PubMed ID: 18005616
[TBL] [Abstract][Full Text] [Related]
24. [Preliminary interpretation on the relationship between the phenotype of CD133+ cells and niche in transplanted human glioma in mice].
Song WC; Fei XF; Dong J
Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):564-9. PubMed ID: 21122405
[TBL] [Abstract][Full Text] [Related]
25. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
[TBL] [Abstract][Full Text] [Related]
26. [Isolation and characterization of brain tumor stem cells in human medulloblastoma].
Li MC; Deng YW; Wu J; Chen FH; Liu JF; Fang JS
Ai Zheng; 2006 Feb; 25(2):241-6. PubMed ID: 16480595
[TBL] [Abstract][Full Text] [Related]
27. An experimental study of dendritic cells transfected with cancer stem-like cells RNA against 9L brain tumors.
Xiao ZY; Tang H; Xu ZM; Yan ZJ; Li P; Cai YQ; Jiang XD; Xu RX
Cancer Biol Ther; 2011 Jun; 11(11):974-80. PubMed ID: 21502808
[TBL] [Abstract][Full Text] [Related]
28. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts.
Fan X; Khaki L; Zhu TS; Soules ME; Talsma CE; Gul N; Koh C; Zhang J; Li YM; Maciaczyk J; Nikkhah G; Dimeco F; Piccirillo S; Vescovi AL; Eberhart CG
Stem Cells; 2010 Jan; 28(1):5-16. PubMed ID: 19904829
[TBL] [Abstract][Full Text] [Related]
29. Presence of glioma stroma mesenchymal stem cells in a murine orthotopic glioma model.
Kim SM; Kang SG; Park NR; Mok HS; Huh YM; Lee SJ; Jeun SS; Hong YK; Park CK; Lang FF
Childs Nerv Syst; 2011 Jun; 27(6):911-22. PubMed ID: 21298274
[TBL] [Abstract][Full Text] [Related]
30. Gliosarcoma stem cells undergo glial and mesenchymal differentiation in vivo.
deCarvalho AC; Nelson K; Lemke N; Lehman NL; Arbab AS; Kalkanis S; Mikkelsen T
Stem Cells; 2010 Feb; 28(2):181-90. PubMed ID: 19937755
[TBL] [Abstract][Full Text] [Related]
31. Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors.
Liu Q; Nguyen DH; Dong Q; Shitaku P; Chung K; Liu OY; Tso JL; Liu JY; Konkankit V; Cloughesy TF; Mischel PS; Lane TF; Liau LM; Nelson SF; Tso CL
J Neurooncol; 2009 Aug; 94(1):1-19. PubMed ID: 19468690
[TBL] [Abstract][Full Text] [Related]
32. Brain tumor stem cells from an adenoid glioblastoma multiforme.
Oka N; Soeda A; Noda S; Iwama T
Neurol Med Chir (Tokyo); 2009 Apr; 49(4):146-50; discussion 150-1. PubMed ID: 19398857
[TBL] [Abstract][Full Text] [Related]
33. Cancer stem cell labeling using poly(L-lysine)-modified iron oxide nanoparticles.
Wang X; Wei F; Liu A; Wang L; Wang JC; Ren L; Liu W; Tu Q; Li L; Wang J
Biomaterials; 2012 May; 33(14):3719-32. PubMed ID: 22342710
[TBL] [Abstract][Full Text] [Related]
34. Patient-derived glioblastoma stem cells are killed by CD133-specific CAR T cells but induce the T cell aging marker CD57.
Zhu X; Prasad S; Gaedicke S; Hettich M; Firat E; Niedermann G
Oncotarget; 2015 Jan; 6(1):171-84. PubMed ID: 25426558
[TBL] [Abstract][Full Text] [Related]
35. Celecoxib and radioresistant glioblastoma-derived CD133+ cells: improvement in radiotherapeutic effects. Laboratory investigation.
Ma HI; Chiou SH; Hueng DY; Tai LK; Huang PI; Kao CL; Chen YW; Sytwu HK
J Neurosurg; 2011 Mar; 114(3):651-62. PubMed ID: 21054139
[TBL] [Abstract][Full Text] [Related]
36. Isolation and characterization of stem cell-like precursor cells from primary human anaplastic oligoastrocytoma.
Yi L; Zhou ZH; Ping YF; Chen JH; Yao XH; Feng H; Lu JY; Wang JM; Bian XW
Mod Pathol; 2007 Oct; 20(10):1061-8. PubMed ID: 17660801
[TBL] [Abstract][Full Text] [Related]
37. CD133+ niches and single cells in glioblastoma have different phenotypes.
Christensen K; Schrøder HD; Kristensen BW
J Neurooncol; 2011 Aug; 104(1):129-43. PubMed ID: 21184132
[TBL] [Abstract][Full Text] [Related]
38. BMI1 sustains human glioblastoma multiforme stem cell renewal.
Abdouh M; Facchino S; Chatoo W; Balasingam V; Ferreira J; Bernier G
J Neurosci; 2009 Jul; 29(28):8884-96. PubMed ID: 19605626
[TBL] [Abstract][Full Text] [Related]
39. Cell death and neuronal differentiation of glioblastoma stem-like cells induced by neurogenic transcription factors.
Guichet PO; Bieche I; Teigell M; Serguera C; Rothhut B; Rigau V; Scamps F; Ripoll C; Vacher S; Taviaux S; Chevassus H; Duffau H; Mallet J; Susini A; Joubert D; Bauchet L; Hugnot JP
Glia; 2013 Feb; 61(2):225-39. PubMed ID: 23047160
[TBL] [Abstract][Full Text] [Related]
40. CXCR4-positive subset of glioma is enriched for cancer stem cells.
Zheng X; Xie Q; Li S; Zhang W
Oncol Res; 2011; 19(12):555-61. PubMed ID: 22812188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
